• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞转化过程中的表观遗传改变。

Epigenetic changes during cell transformation.

机构信息

Department of Pharmacology and Toxicology, College of Pharmacy and The University of Arizona Cancer Center, The University of Arizona, Tucson, AZ 85724-5024, USA.

出版信息

Adv Exp Med Biol. 2013;754:179-94. doi: 10.1007/978-1-4419-9967-2_9.

DOI:10.1007/978-1-4419-9967-2_9
PMID:22956502
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3594783/
Abstract

Malignant cancer emerges from normal healthy cells in a multistep -process that involves both genetic and epigenetic lesions. Both genetic and environmental inputs participate in driving the epigenetic changes that occur during human carcinogenesis. The pathologic changes seen in DNA methylation and histone posttranslational modifications are complex, deeply intertwined, and act in concert to produce malignant transformation. To better understand the causes and consequences of the pathoepigenetic changes in cancer formation, a variety of experimentally tractable human cell line model systems that accurately reflect the molecular alterations seen in the clinical disease have been developed. Results from studies using these cell line model systems suggest that early critical epigenetic events occur in a stepwise fashion prior to cell immortalization. These epigenetic steps coincide with the cell's transition through well-defined cell proliferation barriers of stasis and telomere dysfunction. Following cell immortalization, stressors, such as environmental toxicants, can induce malignant transformation in a process in which the epigenetic changes occur in a smoother progressive fashion, in contrast to the stark stepwise epigenetic changes seen prior to cell immortalization. It is hoped that developing a clearer understanding of the identity, timing, and consequences of these epigenetic lesions will prove useful in future clinical applications that range from early disease detection to therapeutic intervention in malignant cancer.

摘要

恶性肿瘤是从正常健康细胞多步骤演变而来的,这个过程既涉及遗传改变,也涉及表观遗传改变。遗传和环境因素都参与了驱动人类癌症发生过程中发生的表观遗传改变。在 DNA 甲基化和组蛋白翻译后修饰中观察到的病理变化是复杂的、深度交织的,并协同作用产生恶性转化。为了更好地理解癌症形成中病理表观遗传改变的原因和后果,已经开发了多种可在实验中处理的、准确反映临床疾病中分子改变的人类细胞系模型系统。使用这些细胞系模型系统进行的研究结果表明,早期关键的表观遗传事件以前细胞永生化的方式逐步发生。这些表观遗传步骤与细胞通过静止和端粒功能障碍的明确细胞增殖障碍的过渡相吻合。在细胞永生化之后,应激源,如环境毒素,可以在一个过程中诱导恶性转化,在这个过程中,表观遗传变化以更平滑的渐进方式发生,与细胞永生化之前观察到的明显逐步的表观遗传变化形成对比。希望对这些表观遗传损伤的性质、时间和后果有更清晰的认识,将有助于未来的临床应用,从早期疾病检测到恶性癌症的治疗干预。

相似文献

1
Epigenetic changes during cell transformation.细胞转化过程中的表观遗传改变。
Adv Exp Med Biol. 2013;754:179-94. doi: 10.1007/978-1-4419-9967-2_9.
2
Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization.逐步的DNA甲基化变化与摆脱特定增殖障碍和乳腺上皮细胞永生化有关。
Cancer Res. 2009 Jun 15;69(12):5251-8. doi: 10.1158/0008-5472.CAN-08-4977. Epub 2009 Jun 9.
3
Epigenetic roles in the malignant transformation of gastric mucosal cells.表观遗传学在胃黏膜细胞恶性转化中的作用。
Cell Mol Life Sci. 2016 Dec;73(24):4599-4610. doi: 10.1007/s00018-016-2308-9. Epub 2016 Jul 27.
4
"Identification Card": Sites on Histone Modification of Cancer Cell.“识别卡”:癌细胞组蛋白修饰位点
Chin Med Sci J. 2015 Dec;30(4):203-9. doi: 10.1016/s1001-9294(16)30001-3.
5
Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation.异常 DNA 甲基化的聚集与毒物诱导的恶性转化有关。
Epigenetics. 2012 Nov;7(11):1238-48. doi: 10.4161/epi.22163. Epub 2012 Sep 13.
6
Establishing a role for environmental toxicant exposure induced epigenetic remodeling in malignant transformation.确立环境毒物暴露诱导的表观遗传重塑在恶性转化中的作用。
Semin Cancer Biol. 2019 Aug;57:86-94. doi: 10.1016/j.semcancer.2018.11.002. Epub 2018 Nov 16.
7
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.表观遗传药物作为癌症治疗中的多效性药物:生物分子方面及临床应用
J Cell Physiol. 2007 Aug;212(2):330-44. doi: 10.1002/jcp.21066.
8
Epigenetic changes in cancer.癌症中的表观遗传变化。
Annu Rev Pathol. 2009;4:229-49. doi: 10.1146/annurev.pathol.3.121806.151442.
9
Altered primary chromatin structures and their implications in cancer development.改变的初级染色质结构及其在癌症发展中的意义。
Cell Oncol (Dordr). 2016 Jun;39(3):195-210. doi: 10.1007/s13402-016-0276-6. Epub 2016 Mar 23.
10
Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis.乳腺癌中的表观基因组重塑:来自早期体外致癌模型的见解
Breast Cancer Res. 2012 Nov 15;14(6):215. doi: 10.1186/bcr3237.

引用本文的文献

1
The oncogenic role of hypomethylated ZNF793 in gastric carcinoma: a focus on cell survival and stemness.低甲基化ZNF793在胃癌中的致癌作用:聚焦于细胞存活和干性
Gastric Cancer. 2025 Jun 22. doi: 10.1007/s10120-025-01632-8.
2
Diagnostic Value of Methylation for Nasopharyngeal Carcinoma: Meta-Analysis.甲基化对鼻咽癌的诊断价值:Meta分析
Diagnostics (Basel). 2023 Sep 12;13(18):2926. doi: 10.3390/diagnostics13182926.
3
Pragmatic Expectancy on Microbiota and Non-Small Cell Lung Cancer: A Narrative Review.微生物群与非小细胞肺癌的实用预期:一篇叙述性综述
Cancers (Basel). 2022 Jun 26;14(13):3131. doi: 10.3390/cancers14133131.
4
Tumour suppressor TET2 safeguards enhancers from aberrant DNA methylation and epigenetic reprogramming in ERα-positive breast cancer cells.抑癌基因 TET2 可防止 ERα 阳性乳腺癌细胞中的增强子发生异常 DNA 甲基化和表观遗传重编程。
Epigenetics. 2022 Oct;17(10):1180-1194. doi: 10.1080/15592294.2021.1997405. Epub 2021 Oct 30.
5
hTERT-immortalized gingival fibroblasts respond to cytokines but fail to mimic primary cell responses to Porphyromonas gingivalis.永生化人牙龈成纤维细胞对细胞因子有反应,但无法模拟原代细胞对牙龈卟啉单胞菌的反应。
Sci Rep. 2021 May 24;11(1):10770. doi: 10.1038/s41598-021-90037-5.
6
Comparison of Global DNA Methylation Patterns in Human Melanoma Tissues and Their Derivative Cell Lines.人类黑色素瘤组织及其衍生细胞系中全基因组DNA甲基化模式的比较
Cancers (Basel). 2021 Apr 28;13(9):2123. doi: 10.3390/cancers13092123.
7
The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.p16 基因外显子 1 和外显子 2 的高甲基化:结直肠癌的潜在生物标志物,与癌症病理分期相关。
BMC Cancer. 2018 Oct 22;18(1):1023. doi: 10.1186/s12885-018-4921-5.
8
Decreased expression of the CHD5 gene and its clinicopathological significance in breast cancer: Correlation with aberrant DNA methylation.CHD5基因表达降低及其在乳腺癌中的临床病理意义:与异常DNA甲基化的相关性
Oncol Lett. 2016 Nov;12(5):4021-4026. doi: 10.3892/ol.2016.5147. Epub 2016 Sep 16.
9
Diet-induced obesity modulates epigenetic responses to ionizing radiation in mice.饮食诱导的肥胖会调节小鼠对电离辐射的表观遗传反应。
PLoS One. 2014 Aug 29;9(8):e106277. doi: 10.1371/journal.pone.0106277. eCollection 2014.
10
Identification of a gene signature of a pre-transformation process by senescence evasion in normal human epidermal keratinocytes.在正常人表皮角质形成细胞中通过衰老逃避鉴定预转化过程的基因特征。
Mol Cancer. 2014 Jun 14;13:151. doi: 10.1186/1476-4598-13-151.

本文引用的文献

1
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.p53 通过调节 miRNA 调控上皮-间充质转化和干细胞特性。
Nat Cell Biol. 2011 Mar;13(3):317-23. doi: 10.1038/ncb2173. Epub 2011 Feb 20.
2
Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2.聚(ADP-核糖)聚合酶抑制剂 AG014699 在突变或甲基化 BRCA1 或 BRCA2 的人类癌症中的治疗潜力。
J Natl Cancer Inst. 2011 Feb 16;103(4):334-46. doi: 10.1093/jnci/djq509. Epub 2010 Dec 23.
3
Short tandem repeat profiling: part of an overall strategy for reducing the frequency of cell misidentification.短串联重复序列分析:降低细胞错误鉴定频率的整体策略的一部分。
In Vitro Cell Dev Biol Anim. 2010 Dec;46(10):811-9. doi: 10.1007/s11626-010-9352-9. Epub 2010 Oct 7.
4
Tumor growth inhibition of metastatic nasopharyngeal carcinoma cell lines by low dose of arsenic trioxide via alteration of cell cycle progression and induction of apoptosis.三氧化二砷低剂量抑制转移性鼻咽癌细胞系生长:通过改变细胞周期进程和诱导细胞凋亡。
Head Neck. 2011 May;33(5):734-42. doi: 10.1002/hed.21535. Epub 2010 Aug 24.
5
Conserved role of intragenic DNA methylation in regulating alternative promoters.基因内 DNA 甲基化在调控替代启动子中的保守作用。
Nature. 2010 Jul 8;466(7303):253-7. doi: 10.1038/nature09165.
6
Reduced reactive oxygen species-generating capacity contributes to the enhanced cell growth of arsenic-transformed epithelial cells.活性氧生成能力降低导致砷转化的上皮细胞生长增强。
Cancer Res. 2010 Jun 15;70(12):5127-35. doi: 10.1158/0008-5472.CAN-10-0007. Epub 2010 Jun 1.
7
Arsenic trioxide - An old drug rediscovered.三氧化二砷——一种被重新发现的老药。
Blood Rev. 2010 Jul-Sep;24(4-5):191-9. doi: 10.1016/j.blre.2010.04.001. Epub 2010 May 15.
8
Antitumor effect and mechanisms of arsenic trioxide on subcutaneously implanted human gastric cancer in nude mice.三氧化二砷对裸鼠皮下移植人胃癌的抗肿瘤作用及机制
Cancer Genet Cytogenet. 2010 Apr 15;198(2):90-6. doi: 10.1016/j.cancergencyto.2009.12.015.
9
Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity.通过长距离表观遗传沉默(LRES)将癌症基因组整合到抑制性染色质域中会降低转录可塑性。
Nat Cell Biol. 2010 Mar;12(3):235-46. doi: 10.1038/ncb2023. Epub 2010 Feb 21.
10
Human DNA methylomes at base resolution show widespread epigenomic differences.碱基分辨率下的人类DNA甲基化组显示出广泛的表观基因组差异。
Nature. 2009 Nov 19;462(7271):315-22. doi: 10.1038/nature08514. Epub 2009 Oct 14.